Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · IEX Real-Time Price · USD
1.160
+0.020 (1.75%)
Apr 19, 2024, 11:28 AM EDT - Market open
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $44.23 million as of April 19, 2024. Its market cap has decreased by -17.64% in one year.
Market Cap
44.23M
Enterprise Value
-40.27M
1-Year Change
-17.64%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $44.23M, a decrease of -93.59%. That is a compound annual growth rate of -57.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 43.50M | 2.84% |
Apr 17, 2024 | 42.30M | -3.42% |
Apr 16, 2024 | 43.80M | 1.62% |
Apr 15, 2024 | 43.10M | -5.90% |
Apr 12, 2024 | 45.80M | -5.37% |
Apr 11, 2024 | 48.40M | 1.47% |
Apr 10, 2024 | 47.70M | -2.65% |
Apr 9, 2024 | 49.00M | -6.13% |
Apr 8, 2024 | 52.20M | 2.96% |
Apr 5, 2024 | 50.70M | - |
Apr 4, 2024 | 50.70M | -1.55% |
Apr 3, 2024 | 51.50M | -3.56% |
Apr 2, 2024 | 53.40M | -6.64% |
Apr 1, 2024 | 57.20M | 7.12% |
Mar 28, 2024 | 53.40M | 14.84% |
Mar 27, 2024 | 46.50M | 2.42% |
Mar 26, 2024 | 45.40M | -0.87% |
Mar 25, 2024 | 45.80M | - |
Mar 22, 2024 | 45.80M | 3.62% |
Mar 21, 2024 | 44.20M | 0.45% |
Mar 20, 2024 | 44.00M | 0.69% |
Mar 19, 2024 | 43.70M | 0.92% |
Mar 18, 2024 | 43.30M | 2.85% |
Mar 15, 2024 | 42.10M | 0.72% |
Mar 14, 2024 | 41.80M | -5.00% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Milestone Scientific | 45.04M |
SAB Biotherapeutics | 45.02M |
Xilio Therapeutics | 44.82M |
EUDA Health Holdings | 44.58M |
Aadi Bioscience | 43.95M |
Rockwell Medical | 43.71M |
Ocuphire Pharma | 43.18M |
Quince Therapeutics | 43.06M |